{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:27:02Z","timestamp":1787135222482,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T00:00:00Z","timestamp":1523577600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11239-018-1663-9","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T12:06:19Z","timestamp":1523621179000},"page":"304-309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The course of acquired von Willebrand syndrome during pregnancy among patients with essential thrombocytosis"],"prefix":"10.1007","volume":"46","author":[{"given":"Amihai","family":"Rottenstreich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geffen","family":"Kleinstern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagai","family":"Amsalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9533-5775","authenticated-orcid":false,"given":"Yosef","family":"Kalish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,13]]},"reference":[{"key":"1663_CR1","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","volume":"125","author":"PJ Lenting","year":"2015","unstructured":"Lenting PJ, Christophe OD, Denis CV (2015) von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends. Blood 125:2019\u20132028","journal-title":"Blood"},{"key":"1663_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","volume":"16","author":"KA Bremme","year":"2003","unstructured":"Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16:153\u2013168","journal-title":"Best Pract Res Clin Haematol"},{"key":"1663_CR3","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/hae.13067","volume":"22","author":"L Hawke","year":"2016","unstructured":"Hawke L, Grabell J, Sim W, Thibeault L, Muir E, Hopman W, Smith G, James P (2016) Obstetric bleeding among women with inherited bleeding disorders: a retrospective study. Haemophilia 22:906\u2013911","journal-title":"Haemophilia"},{"key":"1663_CR4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood-2014-08-551960","volume":"125","author":"A Tosetto","year":"2015","unstructured":"Tosetto A, Castaman G (2015) How I treat type 2 variant forms of von Willebrand disease. Blood 125:907\u2013914","journal-title":"Blood"},{"key":"1663_CR5","doi-asserted-by":"crossref","first-page":"e2013052","DOI":"10.4084\/mjhid.2013.052","volume":"5","author":"G Castaman","year":"2013","unstructured":"Castaman G (2013) Changes of von Willebrand factor during pregnancy in women with and without von Willebrand disease. Mediterr J Hematol Infect Dis 5:e2013052","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"1663_CR6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2516.2011.02561.x","volume":"17","author":"FY Huq","year":"2011","unstructured":"Huq FY, Kadir RA (2011) Management of pregnancy, labour and delivery in women with inherited bleeding disorders. Haemophilia 17:20\u201330","journal-title":"Haemophilia"},{"key":"1663_CR7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajh.24607","volume":"92","author":"A Tefferi","year":"2017","unstructured":"Tefferi A (2017) Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 92:94\u2013108","journal-title":"Am J Hematol"},{"key":"1663_CR8","first-page":"5466","volume":"2016","author":"A Rottenstreich","year":"2016","unstructured":"Rottenstreich A, Kleinstern G, Krichevsky S, Varon D, Lavie D, Kalish Y (2016) Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera. Eur J Intern Med 2016:5466","journal-title":"Eur J Intern Med"},{"key":"1663_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bjh.14289","volume":"175","author":"S Alimam","year":"2016","unstructured":"Alimam S, Bewley S, Chappell L, Knight M, Seed P, Gray G, Harrison C, Robinson S (2016) Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study. Br J Haematol 175:31\u201336","journal-title":"Br J Haematol"},{"key":"1663_CR10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ajh.23635","volume":"89","author":"ML Randi","year":"2014","unstructured":"Randi ML, Bertozzi I, Rumi E et al (2014) Pregnancy complications predict thrombotic events in young women with essential thrombocythemia. Am J Hematol 89:306\u2013309","journal-title":"Am J Hematol"},{"key":"1663_CR11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-2006-942763","volume":"32","author":"M Griesshammer","year":"2006","unstructured":"Griesshammer M, Struve S, Harrison CM (2006) Essential thrombocythemia\/polycythemia vera and pregnancy: the need for an observational study in Europe. Semin Thromb Hemost 32:422\u2013429","journal-title":"Semin Thromb Hemost"},{"key":"1663_CR12","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","volume":"110","author":"A Tefferi","year":"2007","unstructured":"Tefferi A, Thiele J, Orazi A et al (2007) Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 110:1092\u20131097","journal-title":"Blood"},{"issue":"2","key":"1663_CR13","first-page":"345","volume":"84","author":"AB Federici","year":"2000","unstructured":"Federici AB, Rand JH, Bucciarelli P et al (2000) Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost 84(2):345\u2013349","journal-title":"Thromb Haemost"},{"key":"1663_CR14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1538-7836.2008.02909.x","volume":"6","author":"A Tiede","year":"2008","unstructured":"Tiede A, Priesack J, Werwitzke S et al (2008) Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost 6:569\u2013576","journal-title":"J Thromb Haemost"},{"key":"1663_CR15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1160\/TH14-02-0108","volume":"112","author":"E Maistre de","year":"2014","unstructured":"de Maistre E, Volot F, Mourey G et al (2014) Performance of two new automated assays for measuring von Willebrand activity:HemosIL AcuStar and innovance. Thromb Haemost 112:825\u2013830","journal-title":"Thromb Haemost"},{"key":"1663_CR16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/hae.12380","volume":"20","author":"J Costa-Pinto","year":"2014","unstructured":"Costa-Pinto J, Perez-Rodriguez A, Gomez-del-Castillo MD et al (2014) Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies. Haemophilia 20:559\u2013567","journal-title":"Haemophilia"},{"issue":"10","key":"1663_CR17","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood-2013-11-539098","volume":"123","author":"E Rumi","year":"2014","unstructured":"Rumi E, Pietra D, Ferretti V et al (2014) JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood 123(10):1544\u20131551","journal-title":"Blood"},{"issue":"4","key":"1663_CR18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2516.2006.01314.x","volume":"12","author":"CA Lee","year":"2006","unstructured":"Lee CA, Chi C, Pavord SR, UK Haemophilia Centre Doctors\u2019 Organization et al. (2006) The obstetric and gynaecological management of women with inherited bleeding disorders\u2014review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors\u2019 Organization. Haemophilia 12(4):301\u2013336","journal-title":"Haemophilia"},{"key":"1663_CR19","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood-2016-05-643346","volume":"128","author":"E Rumi","year":"2016","unstructured":"Rumi E, Cazzola M (2016) How I treat essential thrombocythemia. Blood 128:2403\u20132414","journal-title":"Blood"},{"issue":"2","key":"1663_CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-2003-38836","volume":"29","author":"M Griesshammer","year":"2003","unstructured":"Griesshammer M, Grunewald M, Michiels JJ (2003) Acquired thrombophilia in pregnancy: essential thrombocythemia. Semin Thromb Hemost 29(2):205\u2013212","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"1663_CR21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood-2012-08-448944","volume":"121","author":"T Gernsheimer","year":"2013","unstructured":"Gernsheimer T, James AH, Stasi R (2013) How I treat thrombocytopenia in pregnancy. Blood 121(1):38\u201347","journal-title":"Blood"},{"issue":"5","key":"1663_CR22","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1182\/blood-2010-08-270033","volume":"117","author":"PA Beer","year":"2011","unstructured":"Beer PA, Erber WN, Campbell PJ, Green AR (2011) How I treat essential thrombocythemia. Blood 117(5):1472\u20131482","journal-title":"Blood"},{"key":"1663_CR23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2010.02.036","volume":"203","author":"LD Pacheco","year":"2010","unstructured":"Pacheco LD, Costantine MM, Saade GR, Mucowski S, Hankins GD, Sciscione AC (2010) von Willebrand disease and pregnancy: a practical approach for the diagnosis and treatment. Am J Obstet Gynecol 203:194\u2013200","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"1663_CR24","first-page":"282","volume":"68","author":"M Conti","year":"1986","unstructured":"Conti M, Mari D, Conti E, Muggiasca ML, Mannucci PM (1986) Pregnancy in women with different types of von Willebrand disease. Obstet Gynecol 68(2):282\u2013285","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1663_CR25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","volume":"14","author":"WL Nichols","year":"2008","unstructured":"Nichols WL, Hultin MB, James AH et al (2008) von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 14(2):171\u2013232","journal-title":"Haemophilia"},{"key":"1663_CR26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2516.2011.02573.x","volume":"18","author":"DE Trigg","year":"2012","unstructured":"Trigg DE, Stergiotou I, Peitsidis P, Kadir RA (2012) A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. Haemophilia 18:25\u201333","journal-title":"Haemophilia"},{"key":"1663_CR27","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/jth.12967","volume":"13","author":"S Lancellotti","year":"2015","unstructured":"Lancellotti S, Dragani A, Tartaglione R (2015) Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count. J Thromb Haemost 13:1226\u20131237","journal-title":"J Thromb Haemost"},{"key":"1663_CR28","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/1471-0528.12394","volume":"120","author":"N Burke","year":"2013","unstructured":"Burke N, Flood K, Murray A, Cotter B, Dempsey M, Fay L et al (2013) Platelet reactivity changes significantly throughout all trimesters of pregnancy compared with the nonpregnant state: a prospective study. BJOG 120:1599\u20131604","journal-title":"BJOG"},{"issue":"7","key":"1663_CR29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/s-0036-1587686","volume":"42","author":"E Reynen","year":"2016","unstructured":"Reynen E, James P (2016) Von willebrand disease and pregnancy: a review of evidence and expert opinion. Semin Thromb Hemost 42(7):717\u2013723","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"1663_CR30","first-page":"1368","volume":"62","author":"T Komada","year":"2013","unstructured":"Komada T, Kawasaki T, Sata T (2013) Anesthetic management of emergency cesarean section in a patient with acquired vonWillebrand syndrome. Masui 62(11):1368\u20131371","journal-title":"Masui"},{"key":"1663_CR31","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.ajog.2004.09.020","volume":"192","author":"HS Lipkind","year":"2005","unstructured":"Lipkind HS, Kurtis JD, Powrie R, Carpenter MW (2005) Acquired von Willebrand disease: management of labor and delivery with intravenous dexamethasone, continuous factor concentrate, and immunoglobulin infusion. Am J Obstet Gynecol 192:2067\u20132070","journal-title":"Am J Obstet Gynecol"},{"key":"1663_CR32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/pbc.22084","volume":"53","author":"AA Nageswara Rao","year":"2009","unstructured":"Nageswara Rao AA, Rodriguez V, Long ME, Winters JL, Nichols WL, Pruthi RK (2009) Transient neonatal acquired von Willebrand syndrome due to transplacental transfer of maternal monoclonal antibodies. Pediatr Blood Cancer 53:655\u2013657","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-018-1663-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-018-1663-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-018-1663-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T07:26:34Z","timestamp":1536564394000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-018-1663-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,13]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1663"],"URL":"https:\/\/doi.org\/10.1007\/s11239-018-1663-9","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,13]]}}}